Home
About
About
Leadership
Scientific Advisory Board
Directors
Focus
Neuropathic Corneal Pain
Rare Corneal Disease
NCP Expanded Access
Urcosimod
Mechanism of Action
Preclinical Data
Pipeline
Overview
Urcosimod Development Timeline
Investors
Investors
Share Information
Shareholder Services
Investor Presentation
SEC Filings
Corporate Governance
Corporate Documents
Corporate Information
Corporate Directory
FAQs
News & Presentations
Press releases
Presentations & Publications
Contact
Linkedin
Twitter
Select Page
Hello world!
Mar 20, 2022
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!